Pilar Barretina

13PUBLICATIONS
98CO-AUTHORS
Econometric and statistical methodsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2026
The Contribution of Dostarlimab to First-Line Treatment of Advanced or Recurrent Endometrial Cancer in Spain: A Multi-Criteria Decision Analysis Approach.

|Jul 06, 2026
Multidisciplinary management of advanced ovarian cancer in Spain: expert recommendations for achieving maximum survival and improving patient care.

|Jun 12, 2026
Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review.

|May 12, 2026
Morphological and molecular characterization of epithelial ovarian cancer: SEOM-SEAP consensus guidelines for biomarker integration in clinical practice.

|Apr 14, 2026
Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG Survey.

Desislava Dimitrova, Eleftherios Pierre Samartzis, Dario Zocholl

|Jul 01, 2025
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial.

Kenichi Harano, Roldano Fossati, Beatriz Pardo

Pageof 3

Frequent Collaborators

4 joint publications

Antonio González-Martín

4 joint publications

María Jesús Rubio-Pérez

3 joint publications

Toon Van Gorp

3 joint publications

Luis Manso